Mostrar el registro sencillo

dc.contributor.authorGarcía Hevia, Lorena 
dc.contributor.authorLópez Fanarraga, Mónica 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2021-01-07T15:58:58Z
dc.date.available2021-01-07T15:58:58Z
dc.date.issued2020
dc.identifier.issn1477-3155
dc.identifier.urihttp://hdl.handle.net/10902/20278
dc.description.abstractMicrotubules and carbon nanotubes (CNTs), and more particularly multi-walled CNTs (MWCNTs), share many mechanical and morphological similarities that prompt their association into biosynthetic tubulin filaments both, in vitro and in vivo. Unlike CNTs, microtubules are highly dynamic protein polymers that, upon interaction with these nanomaterials, display enhanced stability that has critical consequences at the cellular level. Among others, CNTs prompt ectopic (acentrosomal) microtubule nucleation and the disassembly of the centrosome, causing a dramatic cytoskeletal reorganization. These changes in the microtubule pattern trigger the generation of ineffective biomechanical forces that result in migration defects, and ultimately in spindle-assembly checkpoint (SAC) blockage and apoptosis. In this review, we describe the molecular mechanism involved in the intrinsic interference of CNTs with the microtubule dynamics and illustrate the consequences of this effect on cell biomechanics. We also discuss the potential application of these synthetic microtubule-stabilizing agents as synergetic agents to boost the effect of classical chemotherapy that includes spindle poisons (i.e. paclitaxel) or DNA interfering agents (5-fluorouracil)-, and list some of the advantages of the use of MWCNTs as adjuvant agents in preventing cell resistance to chemotherapy.es_ES
dc.description.sponsorshipThis research was funded by ISCIII Projects ref. PI19/00349, DTS19/00033, cofunded by European Union FEDER Funds (European Regional Development Fund-ERDF) and IDIVAL for INNVAL19/18, INNVAL 20/13.es_ES
dc.description.sponsorshipThis research was funded by ISCIII Projects ref. PI19/00349, DTS19/00033, cofunded by European Union FEDER Funds (European Regional Development Fund-ERDF) and IDIVAL for INNVAL19/18, INNVAL 20/13.
dc.format.extent11 p.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central - Springer Naturees_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJournal of Nanobiotechnology, 2020, 18(1), 181es_ES
dc.titleMicrotubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatmentes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1186/s12951-020-00742-yes_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1186/s12951-020-00742-y
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

http://creativecommons.org/licenses/by/4.0/Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by/4.0/